APA (7th ed.) Citation

Ma, W., Zhang, B., & Chen, X. (2025). Glucagon‐like pepetide‐1 receptor agonist suggests novel therapeutic options for hypothalamic obesity. Journal of Diabetes Investigation, 16(3), 357. https://doi.org/10.1111/jdi.14372

Chicago Style (17th ed.) Citation

Ma, Wanlu, Bo Zhang, and Xiaoping Chen. "Glucagon‐like Pepetide‐1 Receptor Agonist Suggests Novel Therapeutic Options for Hypothalamic Obesity." Journal of Diabetes Investigation 16, no. 3 (2025): 357. https://doi.org/10.1111/jdi.14372.

MLA (9th ed.) Citation

Ma, Wanlu, et al. "Glucagon‐like Pepetide‐1 Receptor Agonist Suggests Novel Therapeutic Options for Hypothalamic Obesity." Journal of Diabetes Investigation, vol. 16, no. 3, 2025, p. 357, https://doi.org/10.1111/jdi.14372.